Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening-Reference-Cited by-同舟云学术

Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening

Published:2011-06-08 Issue:12 Volume:103 Page:962-978
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Grohar Patrick J.,Woldemichael Girma M.,Griffin Laurie B.,Mendoza Arnulfo,Chen Qing-Rong,Yeung Choh,Currier Duane G.,Davis Sean,Khanna Chand,Khan Javed,McMahon James B.,Helman Lee J.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/103/12/962/17311079/djr156.pdf

Reference69 articles.

1. Mechanisms of sarcoma development;Helman;Nat Rev Cancer.,2003

2. The molecular signature of oncofusion proteins in acute myeloid leukemia;Martens;FEBS Lett.,2010

3. Oncogenic gene fusions in epithelial carcinomas;Prensner;Curr Opin Genet Dev.,2009

4. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours;Delattre;Nature.,1992

5. The Ewing family of tumors—a subgroup of small-round-cell tumors defined by specific chimeric transcripts;Delattre;N Engl J Med.,1994

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EWS-FLI1 and Activator Protein-1 (AP-1) Reciprocally Regulate Extracellular-Matrix Proteins in Ewing sarcoma Cells;International Journal of Molecular Sciences;2024-08-06

2. Mithramycin and its analogs: Molecular features and antitumor action;Pharmacology & Therapeutics;2024-08

3. Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma;Clinical Cancer Research;2024-03-20

4. High-mobility group box 1 increases platelet surface P2Y₁₂ and platelet activation in sickle cell disease;JCI INSIGHT;2024

5. Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the Field;Cancers;2023-08-16